Kyowa Hakko Kirin And Solasia Begin Effort To Bring Cancer Support Therapies To Asia
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin and Solasia Pharma are rolling out the first result of their partnership to bring Western oncology products to Asia, announcing a commercialization agreement that grants Kyowa Hakkko Kirin rights to sell ProStrakan's extended release transdermal Sancuso in some Asian countries